Skip to main content
Caplight Logo









Biobot Surgical

Biobot Surgical

Private
SingaporeHealthcare & Life Scienceshttps://biobotsurgical.com

Last Round

VC Round

Jun 29, 2026

Total Funding Raised

$18M

Company Overview

Biobot Surgical operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a VC Round in June 2026.

Biobot Surgical is a healthcare technology company that develops robotic-assisted surgical systems for minimally invasive prostate biopsies and targeted treatments.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Biobot Surgical Comparables

Compare Biobot Surgical with similar companies based on industry and business-model similarity.

Biobot Surgical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Soteria Medical
85%
KOELIS
84%
Focal Healthcare
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Biobot Surgical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 29, 2026
Series BMar 7, 2024
VC RoundNov 7, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

CHEN HONGJUN

Chief Technology Officer

Executive Team

For institutional investors. Book with your work email.

Biobot Surgical Investors

Notable investors and investment history

Biobot Surgical investors
InvestorRounds
ClavystBioVC Round
ZIG VenturesVC Round, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 7, 2024

    $18M round led by Tony Tan Choon Keat.

Book a demo to see all signals

For institutional investors. Book with your work email.

Biobot Surgical Filings

Explore SEC and related filing metadata, where available.

Biobot Surgical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Biobot Surgical's valuation, stock price, and market status.

Is Biobot Surgical a public or private company?

Biobot Surgical is a private company.

What is the current stock price of Biobot Surgical?

Biobot Surgical is a private company, so its shares have no public market price. Caplight tracks Biobot Surgical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Biobot Surgical worth (valuation)?

Valuation information for Biobot Surgical is not publicly available.

Can I buy Biobot Surgical stock?

Biobot Surgical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Biobot Surgical's last funding round?

Biobot Surgical's most recent funding round was VC Round on June 29, 2026.

Who are the main investors in Biobot Surgical?

Key investors in Biobot Surgical include ClavystBio.

Will Biobot Surgical IPO soon?

No public IPO plans have been announced for Biobot Surgical.

How can I track Biobot Surgical secondary market activity?

Caplight tracks bids, offers, and trades in Biobot Surgical's shares on secondary markets.

Firmographic Details

HeadquartersSingapore
Employee Range37
Year Founded2009
Last FundingJun 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?